RSS

Merck

With a spring in their step, manufacturing experts from pharma and biotech descend on New York to enjoy the offerings from this year’s Interphex meeting. Here’s our brief round-up of what to see from exhibitors at the event on day one… more

News

Science and technology company, Merck, has partnered with Oxford University’s Jenner Institute to develop cost-effective vaccine manufacturing processes, aimed at speeding up vaccine availability. more

News

Merck has revealed its collaboration with US-based Medisafe, which is aimed at helping cardiometabolic patients better manage medication intake and adherence to prescribed treatment regimens through a digital offering. more

News

Science and technology company, Merck, has been named as the overall ‘Best Bioprocessing Supplier’ at the Asia-Pacific Bioprocessing Excellence Awards where it also won the sub-category of ‘Best Bioprocessing Supplier Award for Single-use Systems’. more

News

The Scottish Medicines Consortium (SMC) has issued its final advice, recommending restricted use of cladribine tablets (Mavenclad, Merck) for the treatment of highly active relapsing multiple sclerosis (MS). more

News

Data and analytics company, GlobalData, has revealed its prediction that Merck will lead the way in licensing deals for the year when considering the success of the company since 2016. more

Analysis

Two CE-marked IVD liquid biopsy tests have been launched by molecular diagnostics company, Biocartis Group. — the Idylla ctKRAS Mutation Test and the Idylla ctNRAS-BRAF Mutation Test. more

Technology

Ahead of the government’s announcement of its industrial strategy, it has been revealed that MSD (also known as Merck) will make a landmark investment into the UK’s economy through the opening of a new UK hub, for the research into future treatments. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Patients in England will now have immediate access to the new multiple sclerosis (MS) treatment, cladribine tablets (Mavenclad), thanks to a commercial agreement between the manufacturer, Merck, and NHS England that has been announced today. more

News

Real-world data presented by Merck have demonstrated the long-term clinical effectiveness of golimumab (Simponi) for the treatment of rheumatic diseases. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Merck has revealed, in its third quarter earnings report, that the manufacturing disruptions related to the cyber-attack that happened earlier in the year led to $135 million in lost sales. more

News

Science and technology company, Merck, is investing €35 million in a new production line for the aseptic filling of biotech medicines under isolator at its Bari, Italy, manufacturing site. more

Technology

Science and technology company, Merck, has announced the availability of Mavenclad (cladribine tablets) in the UK and Ireland for the treatment of adults with highly active relapsing multiple sclerosis (MS). more

News

In this article, François Feig, head of Global General Medicine and Endocrinology, Merck, explores technological advancements in healthcare and how they can be used to improve patients’ lives. more

Opinion

A Berlin start-up company, labfolder, has been selected to participate in Merck’s Accelerator programme for three months. more

Technology

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

After the Charlottesville protests over the weekend, during which one woman was killed and several others injured, three business leaders have quit Trump’s council as a result of him not taking a harder stance on the issue. more

News

Following disappointing announcements this week concerning the unmet primary endpoints of their Phase III trials, Merck and AstraZeneca have today revealed they are entering a strategic oncology collaboration. more

News